Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time

Frank G. Sandmann, Margreet G. Franken, Adri Steenhoek and Marc A. Koopmanschap

Health Policy, 2013, vol. 112, issue 3, 285-296

Abstract: To investigate the desirability and feasibility of a cyclic reimbursement process to address uncertainty accompanying initial decision making.

Keywords: Drug reimbursement; Systematic review; Evidence development; Imatinib; Pegfilgrastim; Adalimumab (search for similar items in EconPapers)
Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851013000705
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:112:y:2013:i:3:p:285-296

DOI: 10.1016/j.healthpol.2013.03.006

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().